Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts

por Goletz, Christoph, Lischke, Timo, Harnack, Ulf, Schiele, Phillip, Danielczyk, Antje, Rühmann, Johanna, Goletz, Steffen
Publicado 2018